120 related articles for article (PubMed ID: 11213374)
1. Sarcoidosis in a patient with 5q-myelodysplasia. A possible pathogenetic link between the two diseases.
Airaghi L; Montori D; Zorzi F; Miadonna A; Tedeschi A
Monaldi Arch Chest Dis; 2000 Oct; 55(5):378-80. PubMed ID: 11213374
[TBL] [Abstract][Full Text] [Related]
2. Development of 5q- myelodysplasia in a patient with sarcoidosis.
Tunkel AR; Sebastianelli KJ; Pandit N; Brody JI
Am J Hematol; 1990 Jul; 34(3):225-7. PubMed ID: 2363416
[TBL] [Abstract][Full Text] [Related]
3. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
[TBL] [Abstract][Full Text] [Related]
4. Clonal monosomy 7 and 5q--in a child with myelodysplastic syndrome.
Chantrain C; Vermylen C; Michaux L; Brichard B; Cornu G
Pediatr Hematol Oncol; 2000 Sep; 17(6):505-9. PubMed ID: 10989472
[TBL] [Abstract][Full Text] [Related]
5. [Parallel loss of c-FMS and GM-CSF genes in myeloid leukemias with 5q-chromosome].
Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohy H
Rinsho Ketsueki; 1991 Sep; 32(9):931-7. PubMed ID: 1942539
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
[TBL] [Abstract][Full Text] [Related]
7. Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).
Jarosova M; Nedomova R; Hubacek J; Holzerova M; Mickova P; Katrincsakova B; Pikalova Z; Papajik T; Indrak K
Leuk Res; 2012 Apr; 36(4):e68-70. PubMed ID: 22284693
[No Abstract] [Full Text] [Related]
8. Gaucher disease and myelodysplastic syndrome with isolated del(5q).
Villarrubia J; Rodríguez-Gambarte JD; Abalo L; Vallés A; Alonso-Domínguez JM; Velasco-Rodríguez D
Br J Haematol; 2014 Apr; 165(2):164. PubMed ID: 24611589
[No Abstract] [Full Text] [Related]
9. Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion.
Giagounidis AA; Haase S; Germing U; Heinsch M; Aul C
Acta Haematol; 2005; 113(2):146-9. PubMed ID: 15802895
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P.
Zagaria A; Coccaro N; Tota G; Anelli L; Minervini A; Casieri P; Cellamare A; Minervini CF; Brunetti C; Ricco A; Orsini P; Cumbo C; Specchia G; Albano F
Blood Cells Mol Dis; 2015 Jan; 54(1):51-2. PubMed ID: 25159121
[TBL] [Abstract][Full Text] [Related]
12. The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes.
Melchert M; Kale V; List A
Curr Opin Hematol; 2007 Mar; 14(2):123-9. PubMed ID: 17255789
[TBL] [Abstract][Full Text] [Related]
13. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.
Znoyko I; Stuart RK; Ellingham T; Winters J; Wolff DJ; Quigley DI
Cancer Genet Cytogenet; 2008 May; 183(1):64-8. PubMed ID: 18474300
[TBL] [Abstract][Full Text] [Related]
14. [The 5q- syndrome associated with marked erythroid hypoplasia and Coombs test positive hemolysis].
Ohno T; Hishizawa M; Sugiyama T; Mizumoto T; Furukawa H
Rinsho Ketsueki; 1999 Jun; 40(6):499-504. PubMed ID: 10422288
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
Jädersten M; Saft L; Smith A; Kulasekararaj A; Pomplun S; Göhring G; Hedlund A; Hast R; Schlegelberger B; Porwit A; Hellström-Lindberg E; Mufti GJ
J Clin Oncol; 2011 May; 29(15):1971-9. PubMed ID: 21519010
[TBL] [Abstract][Full Text] [Related]
16. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
Rosenfeld CS; Nemunaitis J; Sherer CR; Zeigler ZR; Shadduck RK
Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
[TBL] [Abstract][Full Text] [Related]
17. [Myelodysplastic syndrome associated with 5q deletion, review of 3 cases].
Khanfir A; Frikha M; Mseddi S; Elloumi M; Daoud J; Makni F; Amouri A; Gargouri J; Saad A; Souissi T
Tunis Med; 1997 Mar; 75(3):127-31. PubMed ID: 9506035
[No Abstract] [Full Text] [Related]
18. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
[TBL] [Abstract][Full Text] [Related]
19. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
Pedersen B
Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic mechanisms of action of lenalidomide efficacy in del(5q) myelodysplastic syndromes.
Heise C; Carter T; Schafer P; Chopra R
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1663-72. PubMed ID: 20942636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
